News
Media
Conferences
Resources
Publications
Events
Business
Practice Type
Subscribe
Total Pharmacy

Matthew Davis, PharmD

Articles by Matthew Davis, PharmD

Betrixaban for Prophylaxis of Venous Thromboembolism

ByGianna Casal, PharmD,Matthew Davis, PharmD,Lisa Holle, PharmD, BCOP, FHOPA

June 4th 2018

Betrixaban has been approved by the FDA for patients at risk for thromboembolisms.

Latest Updated Articles

Betrixaban for Prophylaxis of Venous Thromboembolism
Published: June 4th 2018 | Updated:

Trending on Drug Topics

MDPNP Implementation Will Be Complex Despite Systems Properly in Place | NCPA 2025

Q&A: Why Community Pharmacies are Displeased with the MDPNP | NCPA 2025

© 2025 MJH Life Sciences^®

All rights reserved.